Dr. Matthew Hirsch, Associate Professor of Ophthalmology and CMM investigator, was a featured speaker at The Scientist’s 2025 symposium, “AAV Avenues for Cell and Gene Therapy.”
In his talk, “From All for One Towards One for All,” he shared how his team’s decade-long work in AAV gene therapy for rare eye diseases has expanded toward a single treatment platform with potential to address multiple ocular and immune-related disorders.
Read more about The Scientist‘s 2025 symposium on “AAV avenues for cell and gene therapy” ›